A new research conducted by Dana-Farber Cancer Institute at Harvard University discovered that cannaflavins could be a potential healing substance that can be extracted from cannabis. Cannaflavins could be used to treat some illnesses, including fighting the cells that produce pancreatic cancer. Still, the research points out that more data is needed in order to use this substance as a medical treatment option.
Recent research suggests that cannaflavins, compounds derived from the phytonutrients of the cannabis plant, represent another healing substance of this revolutionary plant that can be used both as an anti-inflammatory and as an analgesic in some patients.
Cannaflavins are compounds derived from flavonoids. These natural substances, together with carotenoids, are responsible for the color and taste in fruits and vegetables and have the potential to become another healing substance that could be obtained thanks to cannabis.
If you want to know more about cannabis, how cannaflavins could serve as another healing substance derived from cannabis, how this substance could help some patients to treat their illness, and to find out the latest hemp news, download the Hemp.im mobile application.
In the specific case of cannabis, cannaflavins play an important role in the color and taste of the strains of this plant. In addition, the pigmentation of some types of cannabis strains has much to do with cannaflavins. Such is the case with some cannabis strains, which are characterized by their purple color.
Growers appreciate these characteristics because they allow the creation of various types of cannabis, some of which are used for medicinal or recreational purposes, depending on the levels of Cannabidiol (CBD) or Tetrahydrocannabinol (THC) they contain.
It is worth noting that approximately 6,000 different flavonoids have been identified in the plants. Of these, 23 are found exclusively in cannabis plants. However, their canonical, therapeutic, and recreational use needs further medical research, so a proper treatment using this substance is still further away.
In this regard, researchers at the Dana-Farber Cancer Institute at Harvard University discovered that cannaflavins fight the cells that produce pancreatic cancer. Likewise, other medical studies pointed out that the intake of cannaflavins favors the protection of the skin, improves brain function, regulates blood sugar, and keeps blood pressure in order.
There are also analyses that allude to the anti-inflammatory potential of cannaflavins in some patients, which could be used by the pharmaceutical industry to develop non-opioid analgesic treatments, useful for various conditions.
It is important to note that cannaflavins are not psychoactive substances, but are believed to act in a similar way to Cannabidiol (CBD), so they may have a synergistic effect in combination with Tetrahydrocannabinol (THC).
Among the cannaflavins with the greatest healing potential are
Considered a precursor to anabolic steroids, beta-sitosterol is a flavonoid found in fruits, vegetables, nuts, and seeds. Even the Food and Drug Administration (FDA) classifies the compound as a heart- attack risk reducer.
Finally, during the 1980s, Dr. Marilyn Barrett isolated cannaflavins A, B, and C to study their analgesic effect. Despite all these studies, its full medicinal potential has not yet been determined.
__
(Featured image by Darko Stojanovic via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Nacion Cannabis, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…
The European Commission has launched an investigation into Italy after its recent proposal to ban…
A new study has found that prolonged use of high-THC cannabis leaves a unique mark…